| 000 | 01743 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515140741.0 | ||
| 264 | 0 | _c20090127 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00820-08 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaléria-Aleixo, A | |
| 245 | 0 | 0 |
_aDrug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cDec 2008 |
||
| 300 |
_a4497-502 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aBrazil |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCodon _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV Seropositivity _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aMartins, A N | |
| 700 | 1 | _aArruda, M B | |
| 700 | 1 | _aBrindeiro, R M | |
| 700 | 1 | _aDa-Silva, R M | |
| 700 | 1 | _aNobre, F F | |
| 700 | 1 | _aGreco, D B | |
| 700 | 1 | _aTanuri, A | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 52 _gno. 12 _gp. 4497-502 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00820-08 _zAvailable from publisher's website |
| 999 |
_c18304538 _d18304538 |
||